Utah Medical Products, Inc. (UTMD)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$71.10+0.55%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · UTMD
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2026 and forward-looking statements relating to 2026 and beyond as presented in a press release dated July 23, 2026. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three months ended March 31, 2026 and forward-looking statements relating to 2026 and beyond as presented in a press release dated April 23, 2026. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and twelve months ended December 31, 2025 and forward-looking statements relating to 2025 and beyond as presented in a press release dated January 29, 2026. The information in this report (including Exhibit 99.1) is being furnished pursuant to
Director — Kevin Timken: Kevin Timken was appointed to the Board of Directors as a new member.
OTHER EVENTS On November 4, 2025, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.31 per share is payable on January 5, 2026 to shareholders of record at the close of business on December 16, 2025. A copy of the press release is attached hereto as Exhibit 99.1.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2025 and forward-looking statements relating to 2025 and beyond as presented in a press release dated October 23, 2025. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2025 and forward-looking statements relating to 2025 and beyond as presented in a press release dated July 24, 2025. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three months ended March 31, 2025 and forward-looking statements relating to 2025 and beyond as presented in a press release dated April 29, 2025. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and twelve months ended December 31, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated January 28, 2025. The information in this report (including Exhibit 99.1) is being furnished pursuant to
OTHER EVENTS On November 5, 2024, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.305 per share is payable on January 3, 2025 to shareholders of record at the close of business on December 16, 2024. A copy of the press release is attached hereto as Exhibit 99.1.
Director — Carrie Leigh: The board increased its size and appointed Carrie Leigh as a new director.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated October 29, 2024. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated July 25, 2024. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three months ended March 31, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated April 25, 2024. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and twelve months ended December 31, 2023 and forward-looking statements relating to 2023 and beyond as presented in a press release dated January 30, 2024. The information in this report (including Exhibit 99.1) is being furnished pursuant to
OTHER EVENTS On October 31, 2023, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.30 per share is payable on January 3, 2024 to shareholders of record at the close of business on December 15, 2023. A copy of the press release is attached hereto as Exhibit 99.1
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2023 and forward-looking statements relating to 2023 and beyond as presented in a press release dated October 26, 2023. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2023 and forward-looking statements relating to 2023 and beyond as presented in a press release dated July 25, 2023. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three months ended March 31, 2023 and forward-looking statements relating to 2023 and beyond as presented in a press release dated April 25, 2023. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and twelve months ended December 31, 2022 and forward-looking statements relating to 2022 and beyond as presented in a press release dated January 31, 2023. The information in this report (including Exhibit 99.1) is being furnished pursuant to
OTHER EVENTS On November 1, 2022, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.295 per share is payable on January 4, 2023 to shareholders of record at the close of business on December 16, 2022. A copy of the press release is attached hereto as Exhibit 99.1.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2022 and forward-looking statements relating to 2022 and beyond as presented in a press release dated October 25, 2022. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2022 and forward-looking statements relating to 2022 and beyond as presented in a press release dated July 26, 2022. The information in this report (including Exhibit 99.1) is being furnished pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three months ended March 31, 2022 and forward-looking statements relating to 2022 and beyond as presented in a press release dated April 26, 2022. The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, a…
OTHER EVENTS On February 8, 2022, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.29 per share is payable on April 5, 2022 to shareholders of record at the close of business on March 18, 2022. A copy of the press release is attached hereto as Exhibit 99.1
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.